Update README.md

We hope to introduce drugs or medicines may be withdrawn from commercial markets because of risks to patients, **unapproved drug formulations** or any drug/medications that has a refused market authorization status.

* **No Regulatory Approval**
⚠️ Products lack EMA/FDA authorization for safety/efficacy.
⚠️We do not answer to EMA and are not supervised by european regulatory bodies of any kind.
⚠️ Drugs or medicines which were withdrawn from commercial markets because of risks to patients
⚠️ Abandoned Drugs
⚠️ Drugs with refused market authorization status

🚫**Drugs we want to reintroduce**
[Pheniprazine](https://commonchemistry.cas.org/detail?cas_rn=55-52-7&search=pheniprazine)
[Fenbutrazate](https://commonchemistry.cas.org/detail?cas_rn=4378-36-3)
[Pivhydrazine](https://commonchemistry.cas.org/detail?cas_rn=306-19-4)
[Caroxazone](https://commonchemistry.cas.org/detail?cas_rn=18464-39-6)
[Phenoxypropazine](https://commonchemistry.cas.org/detail?cas_rn=3818-37-9)
[Morforex](https://commonchemistry.cas.org/detail?cas_rn=41152-17-4&search=morforex)
[Phenelzine](https://commonchemistry.cas.org/detail?cas_rn=51-71-8)
[d-Deprenyl](https://commonchemistry.cas.org/detail?cas_rn=4528-51-2)
[Minaprine](https://commonchemistry.cas.org/detail?cas_rn=25905-77-5)
[Iproniazid](https://commonchemistry.cas.org/detail?cas_rn=54-92-2)
[Nikethamide](https://commonchemistry.cas.org/detail?cas_rn=59-26-7)
[Clobenzorex](https://commonchemistry.cas.org/detail?cas_rn=13364-32-4)
[Phenatine](https://commonchemistry.cas.org/detail?cas_rn=139-68-4)
[3-Pyridylnicotinamide](https://commonchemistry.cas.org/detail?cas_rn=13160-06-0)

README.md

@@ -1,3 +1,16 @@
----
-license: gpl-3.0
----
+---
+license: gpl-3.0
+task_categories:
+- summarization
+language:
+- en
+tags:
+- chemistry
+- medical
+- synthetic
+- finance
+- biology
+pretty_name: Out of The Market Drugs for any reason
+size_categories:
+- n<1K
+---